Spironolactone and amiloride in the treatment of low renin hyperaldosteronism and related syndromes.
D000308:Adrenocortical Hyperfunction / Q000188:drug therapy; D000584:Amiloride / Q000494:pharmacology / Q000627:therapeutic use; D000804:Angiotensin II / Q000097:blood; D001834:Body Water / Q000187:drug effects; D003345:Corticosterone / Q000378:metabolism; D004232:Diuretics / Q000627:therapeutic use*; D005110:Extracellular Space / Q000187:drug effects; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy*; D006973:Hypertension / Q000188:drug therapy; D010953:Plasma Volume / Q000187:drug effects; D011188:Potassium / Q000097:blood; D011719:Pyrazines / Q000627:therapeutic use*; D012083:Renin / Q000097:blood*; D012636:Secretory Rate / Q000187:drug effects; D012964:Sodium / Q000097:blood; D013148:Spironolactone / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014508:Urea / Q000097:blood
D004232:Diuretics; D011719:Pyrazines; D000804:Angiotensin II; D013148:Spironolactone; D000584:Amiloride; D014508:Urea; D012964:Sodium; D012083:Renin; D011188:Potassium; D003345:Corticosterone